MITF and melanoma: To this end, we analyzed the phenotypically diverse tumor cell subpopulations of metastatic melanoma lesions taken at the baseline and after starting immunotherapy based on differential expression of AXL and MITF evaluated by single-cell RNA sequencing (scRNAseq), gene expression analysis and multiplex immunofluorescence (mIF) in situ imaging.